Mostrar el registro sencillo del ítem
Estudio comparativo de la rentabilidad de la Empresa San Farma de los periodos 2020 y 2021.
| dc.contributor.advisor | Espinoza Toalombo, Wilmer Olmedo | |
| dc.contributor.author | León Varas, María Fernanda | |
| dc.date.accessioned | 2022-10-14T00:16:59Z | |
| dc.date.available | 2022-10-14T00:16:59Z | |
| dc.date.issued | 2022 | |
| dc.identifier.uri | http://dspace.utb.edu.ec/handle/49000/12794 | |
| dc.description | The pharmaceutical distributor Sanfarma began operations on August 11, 2015 with the RUC 12053337601, under the name of Sandoya Valero Elsy Carlota. For the comparative study of the business profitability of Sanfarma for the period 2020 - 2021, it is important to highlight that it is an industry model that dominates the commercialization of pharmaceutical products or medicines at the national level, including the existence of monopolistic chains that cover a much of the market. This is the case of Sanfarma, the impact of the pandemic on its profits will be studied through a comparison of the years 2020 and 2021. It is important to know the status and results of the pharmaceutical product distributor Sanfarma, suggest different contexts or methods, Track whether the organization was profitable during the study period, plus what segmentation and analytics used will yield appropriate results by using different formulas. Information on economic indicators should be taken into account, since it will be of great help for the evaluation of the pharmaceutical line, since it may be sufficient to achieve stability or constant profits. The impact of sales on a pharmaceutical distributor's bottom line is high, and despite a sharp drop in initial earnings due to restrictions imposed by forced closures and tightening industry conditions, earnings rise significantly as of as operating restrictions apply. strategies. The owner said that the impact of the prices of the products/services on the pharmacy's income was moderate, given the high cost of some medicines and consumables necessary for the pandemic. | es_ES |
| dc.description | The pharmaceutical distributor Sanfarma began operations on August 11, 2015 with the RUC 12053337601, under the name of Sandoya Valero Elsy Carlota. For the comparative study of the business profitability of Sanfarma for the period 2020 - 2021, it is important to highlight that it is an industry model that dominates the commercialization of pharmaceutical products or medicines at the national level, including the existence of monopolistic chains that cover a much of the market. This is the case of Sanfarma, the impact of the pandemic on its profits will be studied through a comparison of the years 2020 and 2021. It is important to know the status and results of the pharmaceutical product distributor Sanfarma, suggest different contexts or methods, Track whether the organization was profitable during the study period, plus what segmentation and analytics used will yield appropriate results by using different formulas. Information on economic indicators should be taken into account, since it will be of great help for the evaluation of the pharmaceutical line, since it may be sufficient to achieve stability or constant profits. The impact of sales on a pharmaceutical distributor's bottom line is high, and despite a sharp drop in initial earnings due to restrictions imposed by forced closures and tightening industry conditions, earnings rise significantly as of as operating restrictions apply. strategies. The owner said that the impact of the prices of the products/services on the pharmacy's income was moderate, given the high cost of some medicines and consumables necessary for the pandemic. | es_ES |
| dc.description.abstract | La distribuidora farmacéutica Sanfarma inició operaciones el 11 de agosto de 2015 con el RUC 12053337601, bajo la razón social de Sandoya Valero Elsy Carlota. Para el estudio comparativo de la rentabilidad empresarial de Sanfarma para el periodo 2020 - 2021, es importante resaltar que se trata de un modelo de industria que domina la comercialización de productos farmacéuticos o medicamentos a nivel nacional, incluyendo la existencia de cadenas monopólicas que abarcan una gran parte del mercado. Este es el caso de Sanfarma, se estudiará el impacto de la pandemia en sus utilidades a través de una comparación de los años 2020 y 2021. Es importante conocer el estado y resultados de la distribuidora de productos farmacéuticos Sanfarma, sugerir diferentes contextos o métodos, realice un seguimiento de si la organización fue rentable durante el período de estudio, además, qué segmentación y análisis utilizados arrojarán resultados apropiados mediante el uso de diferentes fórmulas. Se debe tener en cuenta la información sobre indicadores económicos, ya que será de gran ayuda para la evaluación de la línea farmacéutica, ya que puede ser suficiente para lograr estabilidad o ganancias constantes. El impacto de las ventas en los resultados finales de un distribuidor farmacéutico es alto y, a pesar de una fuerte caída en las ganancias iniciales debido a las restricciones impuestas por los cierres forzosos y las condiciones de ajuste de la industria, las ganancias aumentan significativamente a medida que se aplican las restricciones operativas. estrategias. El propietario dijo que el impacto de los precios de los productos/servicios en los ingresos de la farmacia fue moderado, dado el alto costo de algunos medicamentos y consumibles necesarios para la pandemia. | es_ES |
| dc.format.extent | 29 p. | es_ES |
| dc.language.iso | es | es_ES |
| dc.publisher | Babahoyo: UTB-FAFI. 2022 | es_ES |
| dc.rights | Atribución-NoComercial-SinDerivadas 3.0 Ecuador | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/ec/ | * |
| dc.subject | Rentabilidad | es_ES |
| dc.subject | Ganancias | es_ES |
| dc.subject | Ingresos | es_ES |
| dc.subject | farmacéutica | es_ES |
| dc.subject | Industria | es_ES |
| dc.title | Estudio comparativo de la rentabilidad de la Empresa San Farma de los periodos 2020 y 2021. | es_ES |
| dc.type | bachelorThesis | es_ES |
Ficheros en el ítem
Este ítem aparece en la(s) siguiente(s) colección(ones)
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución-NoComercial-SinDerivadas 3.0 Ecuador